Improving Cancer Screening

Improving Cancer Screening

About the ‘Improving cancer screening’ project

The Group of Chief Scientific Advisors asked SAPEA to produce an Evidence Review Report on the following questions:

“How can cancer screening programmes targeting breast, cervical and colorectal cancers, be improved throughout the EU?

What is the scientific basis for extending such screening programmes to other cancers e.g. lung, prostate and gastric cancers, and ensuring their feasibility throughout the EU?

Which are the main scientific elements to consider, and best practices to promote, for optimising risk-based cancer screening and early diagnosis throughout the EU?”

SAPEA (Science Advice for Policy by European Academies) was asked to produce this Evidence Review Report to inform the Scientific Opinion of the European Commission’s Group of Chief Scientific Advisors (GCSA).

AE Cardiff’s role in the ‘Improving cancer screening’ project

Academia Europaea oversaw the production of the three rapid reviews, as well as coordinating the peer review of the SAPEA report. All documents can be found on the SAPEA website.


The SAPEA Evidence Review Report, together with supporting reviews and documents and the Scientific Opinion of the Group of Chief Scientific Advisors, were published on 2nd March 2022. All documents can be found on the SAPEA website.

Public engagement

Following the launch of the report in March 2022, there is an extensive campaign of promotion and outreach throughout 2022. 

Latest news about ‘Improving cancer screening’

For latest news about Improving cancer screeningclick here.

More about our SAPEA work

Read more about the Hub’s work on SAPEA here.

SAPEA is funded by the European Union. Views and opinions expressed are those of the authors only, and do not necessarily reflect those of the EU or the European Commission, neither of which can be held responsible for them.